Precision Medicine Navigators Increase Prostate Cancer Genomic Testing Rates
University of Maryland researchers have significantly increased prostate cancer genomic testing rates by implementing Precision Medicine Navigators (PMNs). This intervention closed critical equity gaps, increasing test uptake by over 50 ... Read More